OpenClinica Blog

ICYMI, OpenClinica acquired Build Clinical, now called OpenClinica Recruit, last year. The company’s track record of success led to the…

Satisfied – and repeat – customers are the heart of the success of OpenClinica Recruit. Given the difficulties many organizations…

At OpenClinica, we are especially proud of the work we are doing with the I-SPY 2 Trial, sponsored and operated…

The protocol is the brain of a study. It’s time we gave it a digital body.” In clinical trials, the…

As we wrote in our new case study, The I-SPY series of trials are reshaping the future of personalized oncology…

As funding for clinical research becomes increasingly uncertain, with significant research budget cuts announced by federal agencies like the National…

Quite simply, getting patients to participate in clinical trials is far from easy. Widely reported statistics suggest that only 2-5…

Without a doubt, oncology clinical trials are among the most complex and complicated trials. Two of the primary reasons are:…

The inclusion of participants who lack the capacity for informed consent is essential for ensuring the generalizability of clinical trial…

Chris Weiss, OpenClinica’s Vice President of Sales, recently led a short, live demo of our Unite EHR-to-EDC eSource solution. In…

To refresh your memory, EHR-to-EDC integration, also known as EHR eSource, is the process of combining electronic health records (EHR)…

Let’s start with the results for academic research organizations. In short, OpenClinica Recruit (formerly BuildClinical) succeeds in clinical trial patient…

Without a doubt, I wholeheartedly believe EHR-to-EDC integration is the future of clinical trials. There are at least 10 reasons…